Patients suffering from gout often eat cherries to prevent gout attacks. Is there any scientific basis for this?

A specific definition brings erosions back as a criterion in the definition of rheumatoid arthritis

Dr. Lukas Wartman considers the progress being made in genome sequencing and the challenges in bringing these technologies to the clinic.

A pain expert weighs in on an FDA advisory committee's recent vote in favor of reclassifying hydrocodone-containing medications as schedule II.

Drs. Eric Topol and J. Craig Venter explain why the true revolution in medicine is just beginning.

No longer are medical data available only to clinician providers. Why is this important? Dr. Eric Topol explains.

Dr. Eric Topol wonders why anyone would want to visit a hospital or waste time at a physician office visit in the future and offers ways to improve on these models of patient care.

Dr. Jonathon Kay on the American College of Rheumatology’s new gout management guidelines.

A look at how the pharmacotherapeutic management of RA is evolving.

Dr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis.